NEWS
|
2019-1-8 FDA’s Real-time Oncology Review Pilot Program Substantially Reduces the Time to FDA Approval from Filing – Initial Results from Analysis of Blomquist & Associates’ LTTA Oncology Database
|
|
2018-4-26 Blomquist & Associates Releases the First Study of Likelihood Time to Regulatory Approval for Investigational Oncology Drugs in the US and Europe.
|
|
2017-12-6 Changing the game in type 2 diabetes treatment: Some drugs not only lower blood glucose but reduce risk of major cardiovascular events.
|
|
2017-9-15 Immuno-Oncology agent competitiveness in treating Bladder Cancer: Does Tecentriq's failure represent a class effect?
|
|
2017-9-12 The Immuno-Oncology Race: Recent Successes and Failures
|
|
2017-9-8 Trulicity's Sales Trajectory Bests Victoza's in the Diabetes Therapy Market
|
|
2016-10-5 Blomquist & Associates Receives 2016 Best of Boulder Award
|
|